Across TCGA pan-cancer cohorts, CHGB mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CHGB’s most consistent transcriptional readouts.
The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where CHGB mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types CHGB is over-expressed in tumor, although a few such as CCRCC and COAD show the opposite, repressed pattern.
CCRCC, COAD, and PDAC are the cancer types where CHGB tumor–normal differential expression is most reproducible.